[CITATION][C] Results of phase I pharmacokinetic and pharmacodynamic studies of the Raf kinase inhibitor BAY 43-9006 in patients with solid tumors.
D Strumberg, D Voliotis, JG Moeller… - … journal of clinical …, 2002 - europepmc.org
Results of phase I pharmacokinetic and pharmacodynamic studies of the Raf kinase
inhibitor BAY 43-9006 in patients with solid tumors. - Abstract - Europe PMC Sign in | Create
an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us
Helpdesk Feedback Twitter Blog Tech blog Developer Forum Europe PMC plus Search life-sciences
literature (Over 40 million articles, preprints and more) Search Advanced search Feedback
This website requires cookies, and the limited processing of your personal data in order to …
inhibitor BAY 43-9006 in patients with solid tumors. - Abstract - Europe PMC Sign in | Create
an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us
Helpdesk Feedback Twitter Blog Tech blog Developer Forum Europe PMC plus Search life-sciences
literature (Over 40 million articles, preprints and more) Search Advanced search Feedback
This website requires cookies, and the limited processing of your personal data in order to …
